N'oge na-adịbeghị anya, teknụzụ ndị ama ama na-adịbeghị anya.
Ngosiputa ahia ahia mbu
Leuprorelin acetate bu ọgwụ a na-eji eme ọgwụgwọ na-emeso ọrịa hormone na-agwọ ọrịa homonụ, yana usoro molecular c59h84n16o12 •. Ọ bụ Gnaadotropin-Revatotropic na-eme ka amonistone (GNRha) na-arụ ọrụ site na igbochi nsogbu nke Gonadary-gnadary. Na mbụ a na-emepụta ihe na Abbvie na ọgwụ na-egbu egbu, a na-ere ọgwụ a n'okpuru aha ụdị dị iche iche na mba dị iche iche. Na United States, a na-ere ya n'okpuru aha akara Lupron depot, mgbe ọ na China, a na-ere ya dị ka Yina.
Usoro doro anya na ọrụ akọwapụtara nke ọma
Site na afọ 2019 ruo 2022, emechara nyocha ọgwụ na mmepe, ndị ndebanye aha API na March 2024, mgbe anabataghị nnabata. A na-agabiga nyocha nke ọgwụ August 2024. Ọ bụ teknụzụ usoro ọgwụgwọ, ihe ọmụmụ usoro, ihe nhazi ya na usoro nhazi. Hubei JX bio bio-remicoutuoutical COMACARACE na-ahụ maka mmepụta nhazi usoro, usoro nkwado usoro, na ụlọ ọrụ kwụ ọtọ maka API.
Azụ ahịa na-eto eto
Ọnọdụ na-ebili nke kansaụ cancer na fibroids uterine na-akwọ ụgbọala na-abawanye na Leuprorelin a. Ahịa ndị dị na North America ugbu a na-achịkwa ahịa aceprelin ugbu a, na-eme ihe na-eto eto na nnabata dị elu nke teknụzụ ọhụrụ bụ ndị ọkwọ ụgbọ mmiri. N'otu oge, ahịa Eshia, ọkachasị China, na-egosipụta oke ọchụchọ maka Leuprorelin acetate. Due to its effectiveness, global demand for this drug is on the rise, with the market size expected to reach USD 3,946.1 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.86% from 2021 to 2031.
Banyere joymed
E guzobere teknụzụ Shenzhen jupụtara na teknụzụ. Site na otu ụlọ nyocha na ntọala ntọala ihe atọ na-enye ihe, ọ bụ otu n'ime ndị kasị na-emepụta nke kemịkal nke API NA China. Companylọ ọrụ isi R & D si na-anya isi ihe karịrị afọ 20 nke ahụmịhe na ụlọ ọrụ Peptide ma nweela nyocha FDA nke ọma ugboro abụọ. Sistem na-eme ka peptionization na arụmọrụ nke na-enye ndị ahịa ihe zuru oke nke ọrụ zuru oke, gụnyere mmepe na mmepụta nke ọgwụgwọ, yana nkwado na nkwado nhazi.
Ọrụ azụmahịa kachasị
1.Mastic na International Debanye aha Petsis APIS
2.Veneriary na cosmetic peptides
3.custom peptise na cro, ọrụ OEM
4.PDc ọgwụ (peptide-radionclide, cetide-moleku, protein-protein, protoin-rapa)
Na mgbakwunye na Leuprorelin acetate, jinmed etinyela ndọpụta ndebanye aha na FDA na CDE maka ọgwụ ọgwụ API ọzọ dị ka sembaglutide, liraglutide na tirtzepatide. Ndị ahịa na-eji ihe ndị a ga-eme n'ọdịnihu ga-enwe ike ịdebanye aha nọmba nke CDe ma ọ bụ nọmba DMF mgbe ịnyefe ngwa ndebanye na FDA ma ọ bụ CDE. Nke a ga --emelata oge achọrọ maka ịkwadebe akwụkwọ ngwa, yana oge nyocha na ọnụ ahịa nyocha ngwaahịa.
Kpọtụrụ anyị
Shenzhen Chọọnụ na teknụzụ CO., LTD.
Adreesị:8th & 9th 1, ụlọ nke 1, Shenzhen Bimedical Park na-emepụta ihe, Mba 14 Jiinzi Insisty, Kenzi sunsisty, Pingshan District, Shenzhen
Ekwentị:+86 755-26612112
Weebụ:http://www.jmedtech.com/
Oge Post: Ọgọst-29-2024
